Rapid investigation of the alteration in biochemical profile of maize seedlings treated with aluminium oxide nanoparticles using spectroscopic techniques.

The present study demonstrates the applicability of non-destructive and rapid spectroscopic techniques, specifically laser-induced fluorescence, ultraviolet-visible, and confocal micro-Raman spectroscopy, as non-invasive, eco-friendly, and robust multi-compound analytical methods for assessing biochemical changes in maize seedling leaves resulting from the treatment of aluminium oxide nanoparticles. The recorded fluorescence spectrum of the leaves shows that the treatment of different concentration of aluminium oxide nanoparticles decreases the chlorophyll content as observed by the increase in fluorescence emission intensity ratio (FIR = I/I). The analysis of ultraviolet-visible absorption measurements reveals that the amount of chlorophyll a, chlorophyll b, total chlorophyll and carotenoid decrease for treated plants with respect to untreated seedlings.

A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL) in infants.

A fully liquid hexavalent containing Diphtheria (D), Tetanus (T) toxoids, whole cell Pertussis (wP), Hepatitis B (Hep B), type 1, 2, 3 of inactivated poliovirus (IPV) and Haemophilus influenzae type b (Hib) conjugate vaccine (DTwP-HepB-IPV-Hib vaccine, HEXASIIL) was tested for lot-to-lot consistency and non-inferiority against licensed DTwP-HepB-Hib + IPV in an open label, randomized Phase II/III study. In Phase III part, healthy infants received DTwP-HepB-IPV-Hib or DTwP-HepB-Hib + IPV vaccines at 6, 10 and 14 weeks of age. Blood samples were collected prior to the first dose and 28 days, post dose 3.

Immunogenicity and safety of Havisure vaccine developed by Human Biologicals Institute in healthy subjects of 12 months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority study.

Background: Hepatitis A is an inflammation of the liver caused by the hepatitis A virus (HAV). It is transmitted mainly because of poor personal hygiene via the faecal/oral route through ingestion of contaminated food or water or through the direct contact with an infectious person. Though most of the infected individuals recover from the infection, a few may develop fatal fulminant hepatitis.

Long-term Persistence of Immunogenicity After Primary Vaccination and Response to Booster Vaccination With Typhoid Conjugate Vaccine: Results of a Phase IV Extension Study.

Objective: To evaluate the persistence of antibodies three years after primary vaccination with typhoid conjugate vaccine (TCV) of either Cadila Healthcare Ltd. (Cadila-TCV) or Bharat Biotech International Ltd. (Bharat-TCV) administered in a previous phase II/III study, and to study the booster dose response to Cadila-TCV.